Integration of optimized substituent patterns to produce highly potent 4-aryl-pyridine glucagon receptor antagonists

Optimized substituent patterns in 4-aryl-pyridine glucagon receptor antagonists were merged to produce highly potent derivatives containing both a 3-[(1 R)-hydroxyethyl] and a 2′-hydroxy group. Due to restricted rotation of the phenyl–pyridine bond, these analogues exist as four isomers. A diastereo...

Full description

Saved in:
Bibliographic Details
Published inBioorganic & medicinal chemistry letters Vol. 12; no. 23; pp. 3421 - 3424
Main Authors Ladouceur, Gaetan H., Cook, James H., Hertzog, Donald L., Jones, J.Howard, Hundertmark, Thomas, Korpusik, Mary, Lease, Timothy G., Livingston, James N., MacDougall, Margit L., Osterhout, Martin H., Phelan, Kathleen, Romero, Romulo H., Schoen, William R., Shao, Chunning, Smith, Roger A.
Format Journal Article
LanguageEnglish
Published Oxford Elsevier Ltd 02.12.2002
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Optimized substituent patterns in 4-aryl-pyridine glucagon receptor antagonists were merged to produce highly potent derivatives containing both a 3-[(1 R)-hydroxyethyl] and a 2′-hydroxy group. Due to restricted rotation of the phenyl–pyridine bond, these analogues exist as four isomers. A diastereoselective methylcopper reaction was developed to facilitate the synthesis, and single isomers were isolated with activities in the range IC 50=10–25 nM. Optimized substituent patterns in 4-aryl-pyridine glucagon receptor antagonists were merged to produce highly potent derivatives containing both a 3-[(1 R)-hydroxyethyl] and a 2′-hydroxy group. Due to restricted rotation of the phenyl–pyridine bond, these analogues exist as four isomers. A diastereoselective methylcopper reaction was developed to facilitate the synthesis, and single isomers were isolated with activities in the range IC 50=10–25 nM.
AbstractList Optimized substituent patterns in 4-aryl-pyridine glucagon receptor antagonists were merged to produce highly potent derivatives containing both a 3-[(1 R)-hydroxyethyl] and a 2′-hydroxy group. Due to restricted rotation of the phenyl–pyridine bond, these analogues exist as four isomers. A diastereoselective methylcopper reaction was developed to facilitate the synthesis, and single isomers were isolated with activities in the range IC 50=10–25 nM. Optimized substituent patterns in 4-aryl-pyridine glucagon receptor antagonists were merged to produce highly potent derivatives containing both a 3-[(1 R)-hydroxyethyl] and a 2′-hydroxy group. Due to restricted rotation of the phenyl–pyridine bond, these analogues exist as four isomers. A diastereoselective methylcopper reaction was developed to facilitate the synthesis, and single isomers were isolated with activities in the range IC 50=10–25 nM.
Optimized substituent patterns in 4-aryl-pyridine glucagon receptor antagonists were merged to produce highly potent derivatives containing both a 3-[(1R)-hydroxyethyl] and a 2'-hydroxy group. Due to restricted rotation of the phenyl-pyridine bond, these analogues exist as four isomers. A diastereoselective methylcopper reaction was developed to facilitate the synthesis, and single isomers were isolated with activities in the range IC(50)=10-25 nM.
Author Cook, James H.
Osterhout, Martin H.
Shao, Chunning
Korpusik, Mary
Schoen, William R.
Livingston, James N.
Romero, Romulo H.
Hertzog, Donald L.
Smith, Roger A.
Ladouceur, Gaetan H.
Hundertmark, Thomas
Lease, Timothy G.
Jones, J.Howard
MacDougall, Margit L.
Phelan, Kathleen
Author_xml – sequence: 1
  givenname: Gaetan H.
  surname: Ladouceur
  fullname: Ladouceur, Gaetan H.
  email: gaetan.ladouceur.b@bayer.com
  organization: Department of Chemistry Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA
– sequence: 2
  givenname: James H.
  surname: Cook
  fullname: Cook, James H.
  organization: Department of Chemistry Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA
– sequence: 3
  givenname: Donald L.
  surname: Hertzog
  fullname: Hertzog, Donald L.
  organization: Department of Chemistry Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA
– sequence: 4
  givenname: J.Howard
  surname: Jones
  fullname: Jones, J.Howard
  organization: Department of Chemistry Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA
– sequence: 5
  givenname: Thomas
  surname: Hundertmark
  fullname: Hundertmark, Thomas
  organization: Department of Chemistry Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA
– sequence: 6
  givenname: Mary
  surname: Korpusik
  fullname: Korpusik, Mary
  organization: Department of Chemistry Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA
– sequence: 7
  givenname: Timothy G.
  surname: Lease
  fullname: Lease, Timothy G.
  organization: Department of Chemistry Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA
– sequence: 8
  givenname: James N.
  surname: Livingston
  fullname: Livingston, James N.
  organization: Department of Metabolic Disorders Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA
– sequence: 9
  givenname: Margit L.
  surname: MacDougall
  fullname: MacDougall, Margit L.
  organization: Department of Metabolic Disorders Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA
– sequence: 10
  givenname: Martin H.
  surname: Osterhout
  fullname: Osterhout, Martin H.
  organization: Department of Chemistry Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA
– sequence: 11
  givenname: Kathleen
  surname: Phelan
  fullname: Phelan, Kathleen
  organization: Department of Chemistry Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA
– sequence: 12
  givenname: Romulo H.
  surname: Romero
  fullname: Romero, Romulo H.
  organization: Department of Chemistry Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA
– sequence: 13
  givenname: William R.
  surname: Schoen
  fullname: Schoen, William R.
  organization: Department of Chemistry Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA
– sequence: 14
  givenname: Chunning
  surname: Shao
  fullname: Shao, Chunning
  organization: Department of Chemistry Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA
– sequence: 15
  givenname: Roger A.
  surname: Smith
  fullname: Smith, Roger A.
  organization: Department of Chemistry Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14493149$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/12419375$$D View this record in MEDLINE/PubMed
BookMark eNqFkMFq3DAQhkVISTZpHiFFl0JzcDuyJHt1KiG0SSDQQ1voTcjyaKPilYwkB7ZPXzu7JMecBobv_5n5zshxiAEJuWTwmQFrvvwE1UC1VuLPJ6ivAFreVOqIrJhoRMUFyGOyekFOyVnOfwGYACFOyCmrBVO8lStS7kPBTTLFx0Cjo3Esfuv_YU_z1OXiy4Sh0NGUgilkWiIdU-wni_TRbx6HHR1jWQhRmbQbqnGXfO8D0s0wWbOZOxNaHEtM1ISyLHwu-T1558yQ8eIwz8nv799-3dxVDz9u72-uHyrLFS-VtMCFRSWsNNw0NUrZKZxfU73o1hIaqVpnG-fWqpNGCd45aFlr1wZqU9eOnxO577Up5pzQ6TH57XyoZqAXi_rZol4Uaaj1s0Wt5tyHfW6cui32r6mDthn4eABMtmZwyQTr8ysnhOJMLEVf9xzOXz55TDpbj8Fi72cvRffRv3HKf54OlBg
CitedBy_id crossref_primary_10_1016_j_bmc_2005_10_008
crossref_primary_10_1002_adsc_201300211
crossref_primary_10_1002_chin_200312132
crossref_primary_10_4155_fmc_13_13
crossref_primary_10_1070_RC2008v077n12ABEH003783
crossref_primary_10_1210_er_2006_0026
crossref_primary_10_1517_13543776_15_12_1739
crossref_primary_10_1016_j_bmcl_2006_11_014
crossref_primary_10_1021_jm300579z
Cites_doi 10.1016/S0065-7743(08)60581-3
10.1074/jbc.274.13.8694
10.1016/S0065-7743(08)61086-6
10.1016/0196-9781(89)90010-7
10.1056/NEJM198106183042504
10.1056/NEJM197505082921901
10.1016/S0960-894X(01)00766-1
10.1016/S0960-894X(02)00143-9
10.1021/jm9810304
10.1016/0304-4157(94)00015-6
10.1016/0026-0495(78)90291-3
10.1517/13543776.9.6.701
10.1016/S1367-5931(00)00103-4
10.1002/(SICI)1096-9136(199712)14:5+3.3.CO;2-I
10.1146/annurev.bi.60.070191.003253
10.1039/b001971m
ContentType Journal Article
Copyright 2002 Elsevier Science Ltd
2003 INIST-CNRS
Copyright_xml – notice: 2002 Elsevier Science Ltd
– notice: 2003 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
DOI 10.1016/S0960-894X(02)00736-9
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
DatabaseTitleList
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
Chemistry
EISSN 1464-3405
EndPage 3424
ExternalDocumentID 10_1016_S0960_894X_02_00736_9
12419375
14493149
S0960894X02007369
Genre Journal Article
GroupedDBID ---
--K
--M
.HR
.~1
0R~
1B1
1RT
1~.
1~5
23N
4.4
457
4G.
53G
5GY
5VS
6TJ
7-5
71M
8P~
9JM
9JN
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AARLI
AATCM
AAXUO
ABBQC
ABFNM
ABGSF
ABJNI
ABLVK
ABMAC
ABMZM
ABTAH
ABUDA
ABXDB
ABYKQ
ABZDS
ACDAQ
ACGFS
ACIUM
ACNNM
ACRLP
ADBBV
ADECG
ADEZE
ADMUD
ADUVX
AEBSH
AEHWI
AEKER
AENEX
AFFNX
AFKWA
AFTJW
AFXIZ
AFZHZ
AGHFR
AGRDE
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJRQY
AJSZI
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
D0L
DOVZS
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FLBIZ
FNPLU
FYGXN
G-2
G-Q
GBLVA
HEA
HMK
HMO
HMS
HMT
HVGLF
HZ~
IHE
J1W
KOM
LCYCR
LZ2
M29
M2Z
M34
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SAE
SCB
SCC
SDF
SDG
SDP
SES
SEW
SOC
SPC
SPCBC
SPT
SSH
SSK
SSP
SSU
SSZ
T5K
WUQ
XFK
XPP
Y6R
YK3
ZMT
ZY4
~02
~G-
ABPIF
ABPTK
IQODW
AAXKI
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
AFJKZ
CITATION
ID FETCH-LOGICAL-c393t-5c034ce94c5a3a62e55b9e4059d4b8506597fc6ff89b5a943bf0717c8a02a22f3
IEDL.DBID .~1
ISSN 0960-894X
IngestDate Thu Sep 26 18:55:57 EDT 2024
Sat Sep 28 08:38:11 EDT 2024
Sun Oct 22 16:09:36 EDT 2023
Fri Feb 23 02:33:04 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 23
Keywords Pancreatic hormone
Glucagon
Halophenols
Nitrogen heterocycle
Peptide hormone
Non peptide compound
Non insulin dependent diabetes
In vitro
Pyridine derivatives
Hypoglycemic agent
Structure activity relation
Phenols
Peptidergic receptor
Benzenic compound
Antagonist
Fluorine Organic compounds
Chemical synthesis
Diastereomer
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c393t-5c034ce94c5a3a62e55b9e4059d4b8506597fc6ff89b5a943bf0717c8a02a22f3
PMID 12419375
PageCount 4
ParticipantIDs crossref_primary_10_1016_S0960_894X_02_00736_9
pubmed_primary_12419375
pascalfrancis_primary_14493149
elsevier_sciencedirect_doi_10_1016_S0960_894X_02_00736_9
PublicationCentury 2000
PublicationDate 2002-12-02
PublicationDateYYYYMMDD 2002-12-02
PublicationDate_xml – month: 12
  year: 2002
  text: 2002-12-02
  day: 02
PublicationDecade 2000
PublicationPlace Oxford
PublicationPlace_xml – name: Oxford
– name: England
PublicationTitle Bioorganic & medicinal chemistry letters
PublicationTitleAlternate Bioorg Med Chem Lett
PublicationYear 2002
Publisher Elsevier Ltd
Elsevier
Publisher_xml – name: Elsevier Ltd
– name: Elsevier
References Dohlman, Thorner, Caron, Lefkowitz, Christophe, Unger, Orci, Gerich, Lorenzi, Bier, Schneider, Tsalikian, Karam, Forsham, Unger (BIB3) 1991; 60
Livingston, Schoen, Connell, Cascieri, Koch, Ber, Sadowski, Louizides, De Laszlo, Hacker, Hagmann, MacCoss, Chicchi, Vicario, Madsen, Knudsen, Wiberg, Carr (BIB5) 1999; 34
BIB9
Smith, Hertzog, Osterhout, Ladouceur, Korpusik, Bobko, Jones, Phelan, Romero, Hundertmark, MacDougall, Livingston, Schoen (BIB7) 2002; 12
BIB16
BIB17
Amos, McCarty, Zimmet (BIB1) 1997; 14
Sato, Kobayashi, Takahashi, Chiba, Takeda, Kusakabe (BIB11) 1985; 1636
Lloyd-Williams, Giralt (BIB8) 2001; 30
Ladouceur, Cook, Doherty, Schoen, MacDougall, Livingston, Schoen, Ladouceur, Cook, Lease, Wolanin, Kramss, Hertzog, Osterhout (BIB6) 2002; 12
BIB12
BIB13
BIB14
BIB15
Zhang, Moller, Cobb, Dukes (BIB2) 2000; 4
BIB10
Unson, Gurzenda, Merrifield, Salzig, Unson, Merrifield (BIB4) 1989; 10
Ladouceur (10.1016/S0960-894X(02)00736-9_BIB6_1) 2002; 12
Amos (10.1016/S0960-894X(02)00736-9_BIB1) 1997; 14
Zhang (10.1016/S0960-894X(02)00736-9_BIB2_1) 2000; 4
Smith (10.1016/S0960-894X(02)00736-9_BIB7) 2002; 12
Gerich (10.1016/S0960-894X(02)00736-9_BIB3_4) 1975; 292
Lloyd-Williams (10.1016/S0960-894X(02)00736-9_BIB8) 2001; 30
Schoen (10.1016/S0960-894X(02)00736-9_BIB6_2) 2001; 134
Unger (10.1016/S0960-894X(02)00736-9_BIB3_5) 1978; 27
Unger (10.1016/S0960-894X(02)00736-9_BIB3_3) 1981
Dohlman (10.1016/S0960-894X(02)00736-9_BIB3_1) 1991; 60
Cascieri (10.1016/S0960-894X(02)00736-9_BIB5_3) 1999; 274
Madsen (10.1016/S0960-894X(02)00736-9_BIB5_4) 1998; 41
Connell (10.1016/S0960-894X(02)00736-9_BIB5_2) 1999; 9
Cobb (10.1016/S0960-894X(02)00736-9_BIB2_2) 1998; 33
Livingston (10.1016/S0960-894X(02)00736-9_BIB5_1) 1999; 34
Salzig (10.1016/S0960-894X(02)00736-9_BIB4_2) 1996; 45
Christophe (10.1016/S0960-894X(02)00736-9_BIB3_2) 1995; 1241
Sato (10.1016/S0960-894X(02)00736-9_BIB11) 1985; 1636
Unson (10.1016/S0960-894X(02)00736-9_BIB4_1) 1989; 10
References_xml – volume: 60
  start-page: 653
  year: 1991
  ident: BIB3
  publication-title: Annu. Rev. Biochem.
  contributor:
    fullname: Unger
– ident: BIB9
– volume: 1636
  year: 1985
  ident: BIB11
  publication-title: J. Chem. Soc. Comm.
  contributor:
    fullname: Kusakabe
– volume: 4
  start-page: 461
  year: 2000
  ident: BIB2
  publication-title: Curr. Opin. Chem. Biol.
  contributor:
    fullname: Dukes
– volume: 12
  start-page: 1303
  year: 2002
  ident: BIB7
  publication-title: Bioorg. Med. Chem. Lett.
  contributor:
    fullname: Schoen
– ident: BIB10
– ident: BIB13
– volume: 34
  start-page: 189
  year: 1999
  ident: BIB5
  publication-title: Annu. Rep. Med. Chem.
  contributor:
    fullname: Carr
– ident: BIB12
– volume: 10
  start-page: 1171
  year: 1989
  ident: BIB4
  publication-title: Peptides
  contributor:
    fullname: Merrifield
– volume: 30
  start-page: 145
  year: 2001
  ident: BIB8
  publication-title: Chem. Soc. Rev.
  contributor:
    fullname: Giralt
– ident: BIB17
– volume: 12
  start-page: 461
  year: 2002
  ident: BIB6
  article-title: US Patent 6,218,431, 2001
  publication-title: Bioorg. Med. Chem. Lett.
  contributor:
    fullname: Osterhout
– ident: BIB16
– ident: BIB14
– ident: BIB15
– volume: 14,
  year: 1997
  ident: BIB1
  publication-title: Diabetic Med.
  contributor:
    fullname: Zimmet
– volume: 34
  start-page: 189
  year: 1999
  ident: 10.1016/S0960-894X(02)00736-9_BIB5_1
  publication-title: Annu. Rep. Med. Chem.
  doi: 10.1016/S0065-7743(08)60581-3
  contributor:
    fullname: Livingston
– volume: 274
  start-page: 8694
  year: 1999
  ident: 10.1016/S0960-894X(02)00736-9_BIB5_3
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.274.13.8694
  contributor:
    fullname: Cascieri
– volume: 33
  start-page: 213
  year: 1998
  ident: 10.1016/S0960-894X(02)00736-9_BIB2_2
  publication-title: Annu. Rep. Med. Chem.
  doi: 10.1016/S0065-7743(08)61086-6
  contributor:
    fullname: Cobb
– volume: 10
  start-page: 1171
  year: 1989
  ident: 10.1016/S0960-894X(02)00736-9_BIB4_1
  publication-title: Peptides
  doi: 10.1016/0196-9781(89)90010-7
  contributor:
    fullname: Unson
– start-page: 1518
  year: 1981
  ident: 10.1016/S0960-894X(02)00736-9_BIB3_3
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJM198106183042504
  contributor:
    fullname: Unger
– volume: 292
  start-page: 985
  year: 1975
  ident: 10.1016/S0960-894X(02)00736-9_BIB3_4
  publication-title: New Engl. J. Med.
  doi: 10.1056/NEJM197505082921901
  contributor:
    fullname: Gerich
– volume: 12
  start-page: 461
  year: 2002
  ident: 10.1016/S0960-894X(02)00736-9_BIB6_1
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/S0960-894X(01)00766-1
  contributor:
    fullname: Ladouceur
– volume: 12
  start-page: 1303
  year: 2002
  ident: 10.1016/S0960-894X(02)00736-9_BIB7
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/S0960-894X(02)00143-9
  contributor:
    fullname: Smith
– volume: 41
  start-page: 5150
  year: 1998
  ident: 10.1016/S0960-894X(02)00736-9_BIB5_4
  publication-title: J. Med. Chem.
  doi: 10.1021/jm9810304
  contributor:
    fullname: Madsen
– volume: 1241
  start-page: 45
  year: 1995
  ident: 10.1016/S0960-894X(02)00736-9_BIB3_2
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/0304-4157(94)00015-6
  contributor:
    fullname: Christophe
– volume: 134
  start-page: 311111
  year: 2001
  ident: 10.1016/S0960-894X(02)00736-9_BIB6_2
  article-title: US Patent 6,218,431, 2001
  publication-title: Chem. Abstr.
  contributor:
    fullname: Schoen
– volume: 45
  start-page: 220
  year: 1996
  ident: 10.1016/S0960-894X(02)00736-9_BIB4_2
  publication-title: Diabetes
  contributor:
    fullname: Salzig
– volume: 27
  start-page: 1691
  year: 1978
  ident: 10.1016/S0960-894X(02)00736-9_BIB3_5
  publication-title: Metabolism
  doi: 10.1016/0026-0495(78)90291-3
  contributor:
    fullname: Unger
– volume: 9
  start-page: 701
  year: 1999
  ident: 10.1016/S0960-894X(02)00736-9_BIB5_2
  publication-title: Exp. Opin. Ther. Pat
  doi: 10.1517/13543776.9.6.701
  contributor:
    fullname: Connell
– volume: 4
  start-page: 461
  year: 2000
  ident: 10.1016/S0960-894X(02)00736-9_BIB2_1
  publication-title: Curr. Opin. Chem. Biol.
  doi: 10.1016/S1367-5931(00)00103-4
  contributor:
    fullname: Zhang
– volume: 14,
  year: 1997
  ident: 10.1016/S0960-894X(02)00736-9_BIB1
  publication-title: Diabetic Med.
  doi: 10.1002/(SICI)1096-9136(199712)14:5+3.3.CO;2-I
  contributor:
    fullname: Amos
– volume: 60
  start-page: 653
  year: 1991
  ident: 10.1016/S0960-894X(02)00736-9_BIB3_1
  publication-title: Annu. Rev. Biochem.
  doi: 10.1146/annurev.bi.60.070191.003253
  contributor:
    fullname: Dohlman
– volume: 30
  start-page: 145
  year: 2001
  ident: 10.1016/S0960-894X(02)00736-9_BIB8
  publication-title: Chem. Soc. Rev.
  doi: 10.1039/b001971m
  contributor:
    fullname: Lloyd-Williams
– volume: 1636
  year: 1985
  ident: 10.1016/S0960-894X(02)00736-9_BIB11
  publication-title: J. Chem. Soc. Comm.
  contributor:
    fullname: Sato
SSID ssj0014044
Score 1.7997946
Snippet Optimized substituent patterns in 4-aryl-pyridine glucagon receptor antagonists were merged to produce highly potent derivatives containing both a 3-[(1...
Optimized substituent patterns in 4-aryl-pyridine glucagon receptor antagonists were merged to produce highly potent derivatives containing both a...
SourceID crossref
pubmed
pascalfrancis
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 3421
SubjectTerms Benzyl Compounds - chemistry
Benzyl Compounds - pharmacology
Biological and medical sciences
General and cellular metabolism. Vitamins
Inhibitory Concentration 50
Medical sciences
Pharmacology. Drug treatments
Pyridines - chemistry
Pyridines - pharmacology
Receptors, Glucagon - antagonists & inhibitors
Stereoisomerism
Structure-Activity Relationship
Title Integration of optimized substituent patterns to produce highly potent 4-aryl-pyridine glucagon receptor antagonists
URI https://dx.doi.org/10.1016/S0960-894X(02)00736-9
https://www.ncbi.nlm.nih.gov/pubmed/12419375
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB5CAmmhhHbTR5J20aGE9KCsVw_HOi5LwyYlubSBvRlJlspCYptd97A55LdnJNtZEiiFXmU9zMx4HvLMNwBfJS_cWNsiYIYaKtjYUI1eAU0K5pUU2vBYHn11nc5uxOVczrdg2tfChLTKTve3Oj1q625k1FFzVC8Wo5_B-c6UmCfhuo2noYhPoPlDmT59eErzCOgxEUIKJ9Mwe1PF0-4QB08S9i1uQtXf7NObWq-Qar5td_HCCY3G6Pwt7HVeJJm0L_oOtlw5gP1JiRH03Zock5jXGS_MB_Bq2vd0G8DuVfcrfR-aiw4oAhlDKk8q1B13i3tXkBXqkpBAgOaI1BF-s1yRpiJ1BId1JCAc365JXTVhhqB6ub6l9Xq5QDPoSMiB179xTySrqzGiJ8i7MICvsHoPN-fff01ntGvBQC1XvKHSJlxYp4SVmuuUOSmNcujkqUKYAHaH8Yi3qfeZMlIrwY0PAaLNdMI0Y55_gO2yKt0nIIVKUckza84SK_CzVyYTbuy54WOLYqEO4LQnfF63SBv5JgUNOZUHTuUJyyOnclyQ9ezJn4lMjtbgX0uHz9i5OVAIxTFoPICPLX83T9DVQVdOHv7_qUfwuu8lk7DPsN0s_7gv6NI0Zhhldgg7k4sfs-tHtWDzOw
link.rule.ids 315,783,787,4509,24128,27936,27937,45597,45691
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIlEkhGALtDyKDwjBwd2sHyE-ViuqLXR7oZX2ZtmOjVZqk2g3PSwHfjtjJ2FVJITE1fEjmpnMfHbG3wC8k7z0E-PKyBlqqWATSw2iApqVLCgpjOXpevT8Ip9diS8LudiB6XAXJqZV9r6_8-nJW_ct416a42a5HH-L4LtQYpHF4zaeq3twX0R8jEZ9_PN3nkekj0kcUtibxu7bazzdFKnxQ8Y-plmo-luAetSYNYotdPUu_kChKRqdPoHHPYwkJ92bPoUdX41g_6TCLfTNhrwnKbEznZiPYG86FHUbwYN5_y99H9qznikCNUPqQGp0HjfLH74ka3QmMYMA4xFpEv9mtSZtTZrEDutJpDi-3pCmbmMPQc1qc02bzWqJcdCTmARvvuOcKFff4JaeoPJiA77C-hlcnX6-nM5oX4OBOq54S6XLuHBeCScNNznzUlrlEeWpUtjIdocCDy4PoVBWGiW4DXGH6AqTMcNY4M9ht6orfwCkVDl6eebsp8wJ_O6VLYSfBG75xKFdqEM4HgSvm45qQ29z0FBTOmpKZ0wnTWkcUAzq0XdsRmM4-NfQozvq3C4ohOK4azyEF51-t08Q6yCWky__f9W3sDe7nJ_r87OLr6_g4VBYJmOvYbdd3fo3iG9ae5Ts9xdl2_TU
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Integration+of+optimized+substituent+patterns+to+produce+highly+potent+4-aryl-pyridine+glucagon+receptor+antagonists&rft.jtitle=Bioorganic+%26+medicinal+chemistry+letters&rft.au=Ladouceur%2C+Gaetan+H.&rft.au=Cook%2C+James+H.&rft.au=Hertzog%2C+Donald+L.&rft.au=Jones%2C+J.Howard&rft.date=2002-12-02&rft.pub=Elsevier+Ltd&rft.issn=0960-894X&rft.eissn=1464-3405&rft.volume=12&rft.issue=23&rft.spage=3421&rft.epage=3424&rft_id=info:doi/10.1016%2FS0960-894X%2802%2900736-9&rft.externalDocID=S0960894X02007369
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0960-894X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0960-894X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0960-894X&client=summon